APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 2 filers reported holding APREA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $214,000 | +4.4% | 41,965 | 0.0% | 0.30% | -9.7% |
| Q2 2021 | $205,000 | -4.2% | 41,965 | 0.0% | 0.33% | -11.5% |
| Q1 2021 | $214,000 | +3.9% | 41,965 | 0.0% | 0.37% | -1.8% |
| Q4 2020 | $206,000 | -10.0% | 41,965 | +739.3% | 0.38% | +128.9% |
| Q4 2019 | $229,000 | – | 5,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,259,662 | $6,437,000 | 2.66% |
| COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $214,000 | 0.30% |
| Redmile Group, LLC | 694,918 | $3,551,000 | 0.06% |
| Quantamental Technologies LLC | 13,752 | $70,000 | 0.05% |
| KENNEDY CAPITAL MANAGEMENT LLC | 342,486 | $1,750,000 | 0.04% |
| PDT Partners, LLC | 87,734 | $448,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $383,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,100 | $251,000 | 0.01% |
| NEXT Financial Group, Inc | 11,347 | $58,000 | 0.01% |
| Sugarloaf Wealth Management, LLC | 1,500 | $8,000 | 0.00% |